Companies: 10,795·Total market cap: $144.5T
Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc.

LIXTNASDAQHealthcare● Active
$6.92
+$0.27(+4.06%)
Market Cap$85689668
P/E Ratio
52W High$7.5
52W Low$0.64
Overview

Lixte Biotechnology Holdings, Inc. (LIXT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LIXT · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Lixte Biotechnology Holdings, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

LIXT insider buying and selling by quarter

LIXT insider selling · LIXT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
500K250K0
2025 Q2
2025 Q3
2025 Q4
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · LIXT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

LIXT executive sell shares · LIXT board member insider trading · LIXT insider trading SEC filing

Showing 24 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Porter Stuart D

Director

Award

Date

May 29

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Pursglove Geordan Garrett

CEO and Chairman of the Board · Director

Award

Date

Apr 15

Shares

350,000

Price

Value

View Form 4 on SEC.gov

Stazzone Peter

CFO

Award

Date

Apr 15

Shares

50,000

Price

Value

View Form 4 on SEC.gov

Felix Lourdes

Director

Award

Date

Apr 15

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Sawyer Jason David

Director

Award

Date

Apr 15

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Holloway Michael Andrew

Director

Award

Date

Apr 15

Shares

25,000

Price

Value

View Form 4 on SEC.gov

Primus Guy Warren

Director

Award

Date

Apr 15

Shares

25,000

Price

Value

View Form 4 on SEC.gov

van der Baan Bastiaan Jeroen

President and CEO · Director

Purchase

Date

Oct 3

Shares

10,000

Price

$2.80

Value

$28K

View Form 4 on SEC.gov

Bernards Rene

Director

Purchase

Date

Oct 3

Shares

5,527

Price

$2.51

Value

$14K

View Form 4 on SEC.gov

Bernards Rene

Director

Purchase

Date

Oct 2

Shares

4,473

Price

$2.29

Value

$10K

View Form 4 on SEC.gov

van der Baan Bastiaan Jeroen

Director

Purchase

Date

Dec 30

Shares

10,000

Price

$4.90

Value

$49K

View Form 4 on SEC.gov

Bernards Rene

Director

Purchase

Date

Dec 15

Shares

15,000

Price

$0.51

Value

$8K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Dec 9

Shares

1,112

Price

$0.63

Value

$701

View Form 4 on SEC.gov

Bernards Rene

Director

Purchase

Date

Dec 12

Shares

10,000

Price

$0.61

Value

$6K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Nov 22

Shares

2,484

Price

$0.56

Value

$1K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Nov 21

Shares

1,457

Price

$0.56

Value

$816

View Form 4 on SEC.gov

Brown Regina

Director

Purchase

Date

Nov 21

Shares

2,600

Price

$0.58

Value

$2K

View Form 4 on SEC.gov

Brown Regina

Director

Purchase

Date

Nov 21

Shares

2,400

Price

$0.57

Value

$1K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Nov 18

Shares

6,059

Price

$0.56

Value

$3K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Nov 18

Shares

2,500

Price

$0.56

Value

$1K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Nov 18

Shares

7,648

Price

$0.57

Value

$4K

View Form 4 on SEC.gov

FORMAN ERIC

Vice President and COO

Purchase

Date

Nov 17

Shares

4,852

Price

$0.54

Value

$3K

View Form 4 on SEC.gov

Bernards Rene

Director

Purchase

Date

Nov 14

Shares

52,500

Price

$0.53

Value

$28K

View Form 4 on SEC.gov

FORMAN ERIC

Secretary

Other

Date

Dec 17

Shares

1,333,333

Price

Value

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LIXT insider trading

LIXT insider trades

Lixte Biotechnology Holdings, Inc. (LIXT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Porter Stuart D (Director), Pursglove Geordan Garrett (CEO and Chairman of the Board · Director), Stazzone Peter (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. LIXT insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Lixte Biotechnology Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

LIXT insider trading · 5 questions

The insiders of Lixte Biotechnology Holdings, Inc. (LIXT) include executives and directors such as Porter Stuart D (Director), Pursglove Geordan Garrett (CEO and Chairman of the Board · Director), Stazzone Peter (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LIXT board member insider tradingwho are LIXT insidersLIXT insider rosterLixte Biotechnology Holdings, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026